Harold Davis, MD; Ermona McGoodwin, BS; T. Greene Reed, MD, MPH
Ciprofloxacin (Cipro, Miles Inc., West Haven, Connecticut) is a fluorinated quinolone that is a broad-spectrum antibacterial agent. It is recommended for the treatment of infections caused by susceptible bacteria in lower respiratory infections, skin and skin-structure infections, bone and joint infections, urinary-tract infections, and infectious diarrhea. Recommended adult dosages range from 250 mg every 12 hours (for mild urinary-tract infections) to 750 mg every 12 hours (for more severe or complicated infections). Ciprofloxacin oral tablets have been approved for marketing in the United States since October 1987; the drug should not be used in children or pregnant women. Like other
Learn more about subscription options.
Register Now for a free account.
Davis H, McGoodwin E, Reed TG. Anaphylactoid Reactions Reported after Treatment with Ciprofloxacin. Ann Intern Med. 1989;111:1041–1043. doi: 10.7326/0003-4819-111-12-1041
Download citation file:
Published: Ann Intern Med. 1989;111(12):1041-1043.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only